Skip to main content

Table 2 Overview of study compounds used in vivo (alphabetical order)

From: PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine

Compound

Provider

Mechanism of action

Dose, route of administration

Time of injection

Vehicle

GTN

Cambrex (Germany) via RegionH Pharmacy (Denmark)

Nitric oxide (NO) donor

10 mg/kg, i.p

2 h prior to test

12.2% alcohol in saline

Levcromakalim

Tocris, Bio-Techne Ltd (UK)

KATP channel opener

1 mg/kg, i.p

2 h prior to test

2% DMSO in saline

Anti-PACAP mAb

H. Lundbeck (Denmark)

Human anti-PACAP mAb

30 mg/kg, i.p

24 h before first test (pre-treatment)

IgG control mAb in vehicle provided by Lundbeck

Midazolam

Hameln Pharma GMBH (Germany) via RegionH Pharmacy (Denmark

Benzodiazepine

2 mg/kg, i.p

10 min prior to test

Saline

PACAP38

CASLO ApS (Denmark)

PAC1-. VPAC1-2 receptor agonists

2 μg/kg, s.c

1 h prior to test

Saline

Sumatriptan

GlaxoSmithKline (Denmark) via Region Hovedstaden Pharmacy (Denmark

5-HT1B/1D/1F receptor agonist

0.6 mg/kg, i.p

20 min prior to PACAP38 injection

Saline